Verition Fund Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.1K | Sell |
14,583
-31,568
| -68% | -$54.3K | ﹤0.01% | 2816 |
|
|
2025
Q1 | $154K | Buy |
46,151
+10,760
| +30% | +$35.8K | ﹤0.01% | 2434 |
|
|
2024
Q4 | $262K | Buy |
35,391
+11,712
| +49% | +$86.7K | ﹤0.01% | 2202 |
|
|
2024
Q3 | $222K | Buy |
+23,679
| New | +$222K | ﹤0.01% | 2131 |
|
|
2024
Q1 | – | Sell |
-20,149
| Closed | -$164K | – | 2246 |
|
|
2023
Q4 | $164K | Buy |
+20,149
| New | +$164K | ﹤0.01% | 1642 |
|
|
2023
Q2 | – | Sell |
-34,100
| Closed | -$208K | – | 2082 |
|
|
2023
Q1 | $208K | Buy |
+34,100
| New | +$208K | ﹤0.01% | 1587 |
|
|
2021
Q1 | – | Sell |
-20,742
| Closed | -$962K | – | 1518 |
|
|
2020
Q4 | $962K | Sell |
20,742
-14,914
| -42% | -$692K | 0.01% | 427 |
|
|
2020
Q3 | $1.17M | Buy |
35,656
+23,601
| +196% | +$777K | 0.02% | 280 |
|
|
2020
Q2 | $331K | Buy |
+12,055
| New | +$331K | 0.01% | 695 |
|